Vivos Therapeutics, Inc.

VVOS Nasdaq CIK: 0001716166

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 7921 SOUTHPARK PLAZA,, LITTLETON, CO, 80120
Mailing Address 7921 SOUTHPARK PLAZA,, LITTLETON, CO, 80120
Phone (866)908-4867
Fiscal Year End 1231
EIN 813224056

Financial Overview

FY2024

-$13.58M
Net Income
$15.28M
Total Assets
$10.32M
Total Liabilities
$6.26M
Cash & Equivalents
$-2.22
EPS

Recent SEC Filings

Form Type Date Filed Document
3 Initial insider ownership report February 13, 2026 View on SEC
8-K Current report of material events February 6, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
8-K Current report of material events December 17, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
10-Q Quarterly financial report November 19, 2025 View on SEC
8-K Current report of material events November 19, 2025 View on SEC
8-K Current report of material events November 4, 2025 View on SEC
424B5 Prospectus supplement October 24, 2025 View on SEC

Material Events

8-K Other December 5, 2025
Medium Impact
  • Vivos Therapeutics secured a new Promissory Note (loan) of $2,093,340 from Avondale Capital, LLC.
  • Vivos actually received $1,500,000 in cash after upfront fees and discounts.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.